Cervical Cancer: Screening and Prevention

The total CervicalCancer prevalence in the 7MM (the US, EU5 (the UK, Germany, Spain, Italy, and France) and Japan) was found to be 43,514 in 2017. The UnitedStates topped the charts for maximum Cervical cancer prevalence with Spain accounting for the least number of cases in the 7MM.

Screening, coupled with HPV vaccination, has the potential to prevent Cervical cancer. Today, screening has become such a refined tool that has helped researchers to understand cancer almost completely.
The key players in the HPV Vaccine market include GSK and Merck.

For more details, visit:
https://www.delveinsight.com/blog/cervical-cancer-screening/